Hohmann et al. (2016) showed that application of RNAi or the small molecule BI-7273 (Martin et al., 2016) to achieve genetic knock-down or chemical inhibition of BRD9, respectively, induced cell growth inhibition and differentiation of MLL-r leukemia cell lines through down-regulation of MYC. The gene discussed is BRD9; the disease is leukemia.